The Valley Desk

NCT06526793 · Interventional trial

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Overall registry status Recruiting

Phase 2

Conditions B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov